BETA-AMYLOID PROTEIN - ANVISA Registration 80102512521

Access comprehensive regulatory information for BETA-AMYLOID PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512521 and manufactured by FUJIREBIO EUROPE N.V.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including NL COMÉRCIO EXTERIOR LTDA, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80102512521
Registration Details
ANVISA Registration Number: 80102512521
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Aß(1-42) CAL-RVC
Risk Class II

Registration Details

80102512521

25351630898202048

04718143000194

Company Information

Belgium
PT: BÉLGICA

Dates and Status

Aug 03, 2020

VIGENTE

09/18/2025 19:00:01